S2E19: PMOS After the Reproductive Years: Why it doesn’t go away
Welcome to Clearly Hormonal
(formerly Reset Recharge)
PMOS Awareness Month kicks off with a reframe: PMOS is not a condition that resolves once your cycles regulate or once you're done having kids. It is a lifelong cardiometabolic condition that happens to announce itself first through reproductive symptoms. Dr. Komal Patil-Sisodia walks through the three diagnostic criteria (irregular periods, high androgens, and polycystic ovarian morphology) and explains why the biology underneath, insulin resistance, visceral fat, and unfavorable cholesterol, persists even when periods look normal. She unpacks what worsens in perimenopause, the clinical blind spot that causes PMOS histories to get dropped from the chart, and what she actually changes in her own practice: earlier and trend-based lab monitoring, a shift in treatment goals from fertility to long-term metabolic and heart protection, and more individualized hormone therapy decisions.
PMOS Doesn't Retire When Your Periods Do
By Dr. Komal Patil-Sisodia, MD | Eastside Menopause & Metabolism
If you ask most people what PMOS is, you'll hear something about irregular periods or trouble getting pregnant. That's not wrong. It's just incomplete, and that incompleteness has consequences that show up decades later.
PMOS is diagnosed using three signs: irregular periods, high androgen hormones like testosterone and DHEAS, and a particular pattern on ovarian ultrasound called polycystic ovarian morphology. Those three signs make the diagnosis, but they are not the whole disease. Underneath them is a body that tends toward insulin resistance, extra fat around the belly, and a less favorable cholesterol pattern, a pattern that can start as early as the teenage years.
So what happens when periods become regular, either on their own or because a patient is no longer tracking her cycle? The visible sign disappears. The underlying biology does not. And that is the blind spot at the center of this episode.
What Changes at Perimenopause
Three things shift, and for patients with a PMOS history, they tend to shift from a less favorable starting point.
Insulin resistance rises faster. PMOS often comes with some degree of insulin resistance regardless of weight. Perimenopause adds its own wave as estrogen fluctuates and drops, stacking one shift on top of another.
Cholesterol moves in the wrong direction. Perimenopause tends to raise LDL and triglycerides as estrogen's protective effects fade. In patients with PMOS, those numbers often start higher, so the shift lands somewhere worse.
Belly fat becomes more pronounced. Estrogen decline during perimenopause tends to reduce muscle mass and increase fat mass, especially visceral fat, the kind most closely linked to heart and metabolic risk. In PMOS, this pattern is often already present, so the midlife increase can be more noticeable.
The Question Nobody Asks
Picture a patient with a PMOS history whose cycles were regular for ten years. Now, in her forties, they've gone irregular again, this time because of perimenopause, not PMOS. That explanation is correct. But everyone stops there. The patient thinks she's back where she started. The doctor attributes it to perimenopause and moves on. Nobody asks the question that actually matters: does this patient's PMOS history change how we should manage her heart and metabolic health during this transition, regardless of what's causing her cycles to be irregular right now?
That question almost never gets asked, because the way medicine has been trained to think about PMOS is built entirely around reproduction. Once a patient moves past that stage of life, PMOS quietly falls off the problem list. It's a blind spot, but an easy one to fix: ask, at every midlife visit, what a patient's PMOS history means for what we should be watching now.
Why This Is a Heart Health Story
The insulin resistance and cholesterol changes that show up early in PMOS are not just an inconvenience during the reproductive years. They are the opening chapters of a heart health story that keeps being written for decades. By the time a patient with PMOS reaches perimenopause, she may have had twenty-plus years of a less favorable metabolic starting point than her peers, even if nothing about it ever felt urgent. Perimenopause then speeds that story up, for every woman going through the transition, but on a steeper curve for those with a PMOS history.
What This Looks Like in Practice
For patients with PMOS entering perimenopause, a few things change:
Monitoring starts earlier and looks at trends over time, not just whether one number has crossed a line. A fasting glucose moving from 70 to 80 to 90 to 99 over several years is a meaningful trend, even before it reaches a diagnostic threshold.
Treatment goals shift away from ovulation and fertility and toward long-term metabolic and heart protection, including a closer look at insulin-sensitizing medications like metformin or GLP-1s and more proactive cholesterol management.
Hormone therapy decisions get tailored. A PMOS history doesn't automatically rule hormone therapy in or out, but it should shape what type is used, how it's taken, and how closely it's monitored.
The Takeaway
A PMOS history doesn't stop mattering at perimenopause. If anything, it matters more, because this is the window where heart health risk that has been quietly building for years starts to show up clinically. Stop thinking of PMOS as something that only happens during your reproductive years and then goes away. It travels with you for life, and perimenopause is one of the most important checkpoints along that path.
This is the first episode in a four-part PMOS Awareness Month series. Coming up: lean PMOS and why it gets missed, where GLP-1s fit into PMOS care, and the long road to diagnosis many patients face. Join the email list at eastsidemm.com/newsletter to be the first to know when the PMOS mini-course drops.
Follow Dr. Komal Patil-Sisodia:@drpatilsisodia on Instagram and TikTok
This content is for educational purposes only and does not constitute personalized medical advice. Please discuss your specific health concerns with your own healthcare provider.